Showing results (51-60 of 134) with videos related to
Sort By:
Pageof 14
Coronary Artery Disease|November 8, 2017
Prediction of postpercutaneous coronary intervention myocardial infarction: insights from intravascular imaging, coronary flow, and biomarker evaluationStephen P Hoole, Jules Hernández-Sánchez, Adam J Brown, et al.Journal of Applied Physiology (Bethesda, Md. : 1985)|February 11, 2012
Coronary collaterals provide a constant scaffold effect on the left ventricle and limit ischemic left ventricular dysfunction in humansStephen P Hoole, Paul A White, Philip A Read, et al.Circulation. Cardiovascular Interventions|August 20, 2016
Diastolic Backward-Traveling Decompression (Suction) Wave Correlates With Simultaneously Acquired Indices of Diastolic Function and Is Reduced in Left Ventricular StunningAndrew Ladwiniec, Paul A White, Sukhjinder S Nijjer, et al.Cardiovascular Revascularization Medicine : Including Molecular Interventions|October 21, 2021
Trans-Myocardial Blood Interleukin-6 Levels Relate to Intracoronary Imaging-Defined Features of Plaque Vulnerability and Predict Procedure-Induced Myocardial InfarctionPaul Bambrough, Marta Peverelli, Adam J Brown, et al.Journal of Interventional Cardiology|June 13, 2015
Institutional Switch from Transfemoral to Transradial Vascular Access for Percutaneous Coronary Intervention was Associated with a Reduction in Bleeding Events: A Singlecenter Experience of >10,000 Consecutive CasesNikil K Rajani, Adam J Brown, Liam M McCormick, et al.Circulation. Cardiovascular Interventions|May 19, 2011
A pilot study to assess whether glucagon-like peptide-1 protects the heart from ischemic dysfunction and attenuates stunning after coronary balloon occlusion in humansPhilip A Read, Stephen P Hoole, Paul A White, et al.Cardiovascular Revascularization Medicine : Including Molecular Interventions|October 7, 2015
Mid-term clinical outcomes of ABSORB bioresorbable vascular scaffold implantation in a real-world population: A single-center experienceCharis Costopoulos, Matthew C Crowson, Adam J Brown, et al.Heart (British Cardiac Society)|March 23, 2022
Invasive coronary physiology in patients with angina and non-obstructive coronary artery disease: a consensus document from the coronary microvascular dysfunction workstream of the British Heart Foundation/National Institute for Health Research PartnershipDivaka Perera, Colin Berry, Stephen P Hoole, et al.Cardiovascular Diabetology|August 9, 2015
Glucagon-like peptide-1 protects against ischemic left ventricular dysfunction during hyperglycemia in patients with coronary artery disease and type 2 diabetes mellitusLiam M McCormick, Patrick M Heck, Liam S Ring, et al.Circulation. Cardiovascular Interventions|May 23, 2013
Remote ischemic preconditioning improves outcome at 6 years after elective percutaneous coronary intervention: the CRISP stent trial long-term follow-upWilliam R Davies, Adam J Brown, William Watson, et al.Pageof 14